Cell and Gene Commercialization
-
Gene Therapy Deals, Collaborations, & Partnerships With Astellas' Richard Wilson
11/21/2023
Astellas' Richard Wilson is Erin Harris' guest on Cell & Gene: The Podcast to discuss deals and collaborations in gene therapy.
-
Driving Down COGS: Leveraging Automation Technologies And Mitigating Risk
11/17/2023
The technologies aimed at automating and standardizing cell therapy production are poised to offer advanced therapy companies and CDMOs process-level improvements that streamline and accelerate workflows.
-
A Multi-Vector Perspective: LVV And AAV Development And Manufacturing
11/17/2023
Finding a CDMO partner with the resources and expertise to achieve efficient and scalable manufacturing is a key step in achieving the scalable manufacture of safe, effective AAV gene therapies.
-
3 Steps For Cell & Gene Therapy Medical Affairs Teams To Provide Strategic Value
11/15/2023
Historically, medical affairs has been seen as more of a resource, as the group that answers complex scientific questions. However, medical affairs teams at cell and gene therapy companies must be more strategic.
-
Driving Down COGS: Breaking Down Automated Manufacturing
11/7/2023
While working to optimize discrete process steps is important, achieving CAR-T scalability requires finding ways to perform some steps concurrently, necessitating a more holistic approach to innovation.
-
Important Ethical Questions Concerning CGTs
11/3/2023
This is a summary of Alliance For Regenerative Medicine's panel discussion, "The Importance Of Ethics In Gene And Cell Therapy," from this year's Meeting On The Mesa.
-
Inside 2023 Meeting On The Mesa With ARM's COO, Rita Johnson-Greene
10/26/2023
Hear from speakers on the Cell & Gene: The Podcast about Meeting on the Mesa 2023, the events new location for 2024, major topics and trends at this year's event, and ARM's GROW internship program.
-
5 Takeaways From Meeting On The Mesa 2023
10/25/2023
This year's conference delivered outstanding networking, presentations, and panel discussions with industry leaders. Here are 5 of my favorite quotes from this year's participants.
-
Crafting An Effective Commercialization Strategy For CGTs
10/25/2023
Patient access and manufacturing efficiency persist as barriers to widespread adoption of CGTs. An effective commercialization strategy is crucial to expand access to these life-changing therapies.
-
ARM’s 2023 Meeting On The Mesa: Data, Ethics, And More
10/19/2023
ARM's 2023 Meeting on the Mesa was chock full of informative sessions, impactful conversations, partnering opportunities, and peer networking. Here's a brief recap.